NCT06139354 Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault Status COMPLETED Phase NA
NCT06138106 Developing a Nutritional Supplement to Increase Collagen Synthesis in People Status RECRUITING Phase NA
NCT06103682 LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE) Status RECRUITING Phase NA
NCT06103669 Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS) Status RECRUITING Phase NA
NCT06101290 Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) Status RECRUITING Phase NA
NCT06101277 Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) Status RECRUITING Phase NA
NCT06057662 Personalized Comprehensive Diabetes Support for Children With Newly Diagnosed Type 1 Diabetes Status ENROLLING_BY_INVITATION Phase NA
NCT06041048 Investigation of Locus Coeruleus Function in Sustained Attention Status RECRUITING Phase PHASE4
NCT06016634 Alendronate for Osteonecrosis in Adults With Sickle Cell Disease Status RECRUITING Phase PHASE2
NCT05967533 The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors Status SUSPENDED Phase PHASE1
NCT05843448 IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05752292 Study to Understand Risk Information to Support and Empower Status ENROLLING_BY_INVITATION Phase NA
NCT05637814 Dynamic Critical Congenital Heart Screening With Addition of Perfusion Measurements Status RECRUITING Phase NA
NCT05600686 Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma Status RECRUITING Phase PHASE2
NCT05586776 Decolonization to Reduce After-Surgery Events of Surgical Site Infection Status RECRUITING Phase PHASE4